Organon Updates On Phase 2 Elena Study Of Og-6219 For Endometriosis-related Pain
July 2, 2025
Organon, a global healthcare company with a focus on women’s health, announced that the Phase 2 ELENA proof-of-concept study evaluating the investigational candidate OG-6219 in